Table V.
Comparison of curative effects after treatment in three groups of patients [n (%)].
| Groups | Completely effective | Partially effective | Minimal effective | Ineffective | Total effective rate |
|---|---|---|---|---|---|
| Rituximab group (n=79) | 33 (41.77) | 25 (31.65) | 14 (17.72) | 7 (8.86) | 58 (73.42) |
| Cyclophosphamide group (n=86) | 13 (15.12)a | 36 (41.86) | 23 (26.74) | 14 (16.28) | 49 (56.98)a |
| Combined therapy group (n=84) | 58 (69.05)a,b | 17 (20.24)b | 7 (8.33)b | 2 (2.38)b | 75 (89.29)a,b |
| F-value | 50.820 | 9.241 | 9.901 | 9.810 | 0.226 |
| P-value | <0.001 | 0.010 | 0.007 | 0.007 | <0.001 |
a
P<0.05, compared with rituximab group
b
P<0.05, compared with cyclophosphamide group.